US biotech ValCare is to open a centre in Israel to develop a heart valve repair device. The mitral annuloplasty device is implanted using a catheter, thus avoiding open-heart surgery. It prevents mitral valve regurgitation (blood flowing backwards into the heart) affecting 4 million US citizens.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000764830